Mironid

Newhouse, United Kingdom

Mironid is a drug discovery company focused on therapeutics for degenerative kidney diseases, chronic inflammatory diseases, and cancer.

$38.3M raised

Sep 2023

Series A

Top Investors

University of StrathclydeScottish EnterpriseSofinnova PartnersBioGeneration VenturesEuropean Investment Fund

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Mironid raised?

Mironid has raised $38.3M in total funding. The most recent round was Series A. The last funding was announced in September 2023.

Who are Mironid's investors?

Mironid's investors include University of Strathclyde, Scottish Enterprise, Sofinnova Partners, BioGeneration Ventures, European Investment Fund.

Where is Mironid headquartered?

Mironid is headquartered in Newhouse, United Kingdom.

What does Mironid do?

Mironid is a drug discovery company focused on therapeutics for degenerative kidney diseases, chronic inflammatory diseases, and cancer.

What stage is Mironid at?

Mironid is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 13, 2023.

MLA

"Mironid — Funding & Investors." VCBacked, September 13, 2023, https://www.vcbacked.co/company/mironid. Accessed June 17, 2026.

APA

VCBacked. (2023). Mironid — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/mironid

Wikipedia (cite web)

{{cite web |title=Mironid — Funding & Investors |url=https://www.vcbacked.co/company/mironid |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 13, 2023.